JEAN-BERNARD SIMEON
SVP and Head of ViiV US
Jean-Bernard (JB) Simeon became ViiV US Senior Vice President & Head in April 2026 after serving as SVP and Head of Europe and International. He joined ViiV Healthcare from GSK in January 2022. JB started his career with SmithKline Beecham in Belgium in 1998 and has gone on to hold senior roles within GSK including as General Manager in Austria and Belgium and Commercial Director for Specialty Care in Belgium and Luxembourg, as well as several global and above-country roles, including Synflorix Global Marketing Director and New Product Introduction Lead in the Vaccines business. Prior to joining ViiV, JB was SVP and General Manager of GSK in Germany. In this role he drove a fundamental change in the business culture, accelerated the top and profit line growth and established a robust organisation to deliver strong performance in Vaccines and Specialty Care, including the successful launch of Shingrix and the new Oncology and Specialty Care portfolios.
Our Executive Team
YOU MAY ALSO BE INTERESTED IN
We are ViiV Healthcare: 100% dedicated to HIV medicines and research and completely focused on people affected by HIV and AIDS. At ViiV Healthcare we do things differently. From our unique origins to our innovative medicines, we push the boundaries of what people think is possible in HIV treatment and care.
We have established to take a fresh approach to the challenge of HIV. We set ourselves one mission - to leave no person living with HIV behind. Our values and expectations are at the heart of everything we do. They are integral to how we conduct our business and form an important part of our culture.
NP-GBL-HVX-COCO-220025 April 2026
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.
